Cargando…

Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis

BACKGROUND: Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is known as a serious threat to human health worldwide. Limited information is available concerning the prevalence of MDR P. aeruginosa in Iran. The aim of the present study was to investigate the relative frequency of MDR P....

Descripción completa

Detalles Bibliográficos
Autores principales: Vaez, Hamid, Salehi-Abargouei, Amin, Ghalehnoo, Zahra Rashki, Khademi, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276320/
https://www.ncbi.nlm.nih.gov/pubmed/30581263
http://dx.doi.org/10.4103/jgid.jgid_113_17
_version_ 1783377995049730048
author Vaez, Hamid
Salehi-Abargouei, Amin
Ghalehnoo, Zahra Rashki
Khademi, Farzad
author_facet Vaez, Hamid
Salehi-Abargouei, Amin
Ghalehnoo, Zahra Rashki
Khademi, Farzad
author_sort Vaez, Hamid
collection PubMed
description BACKGROUND: Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is known as a serious threat to human health worldwide. Limited information is available concerning the prevalence of MDR P. aeruginosa in Iran. The aim of the present study was to investigate the relative frequency of MDR P. aeruginosa in different parts of Iran. MATERIALS AND METHODS: Using appropriate keywords and well-known English and Persian database, available data about MDR P. aeruginosa in Iran were retrieved. After applying predefined criteria, relevant studies were selected. RESULTS: By using random-effect models, the pooled incidence of MDR P. aeruginosa was estimated 58% (95% confidence interval [CI]; 0.54–0.61). The highest and lowest prevalence of MDR P. aeruginosa were observed in Tehran (100%) (95% CI; 0.94–1.00) and Zahedan (16%) (95% CI; 0.10–0.24), respectively. The highest resistance rate was against ceftazidime (50%) (95% CI; 0.46–0.54) and amikacin (50%) (95% CI; 0.46–0.54). CONCLUSION: Our findings are of concern since they demonstrate the high prevalence rate of MDR P. aeruginosa in the majority of Iranian hospitals.
format Online
Article
Text
id pubmed-6276320
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-62763202018-12-21 Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis Vaez, Hamid Salehi-Abargouei, Amin Ghalehnoo, Zahra Rashki Khademi, Farzad J Glob Infect Dis Original Article BACKGROUND: Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is known as a serious threat to human health worldwide. Limited information is available concerning the prevalence of MDR P. aeruginosa in Iran. The aim of the present study was to investigate the relative frequency of MDR P. aeruginosa in different parts of Iran. MATERIALS AND METHODS: Using appropriate keywords and well-known English and Persian database, available data about MDR P. aeruginosa in Iran were retrieved. After applying predefined criteria, relevant studies were selected. RESULTS: By using random-effect models, the pooled incidence of MDR P. aeruginosa was estimated 58% (95% confidence interval [CI]; 0.54–0.61). The highest and lowest prevalence of MDR P. aeruginosa were observed in Tehran (100%) (95% CI; 0.94–1.00) and Zahedan (16%) (95% CI; 0.10–0.24), respectively. The highest resistance rate was against ceftazidime (50%) (95% CI; 0.46–0.54) and amikacin (50%) (95% CI; 0.46–0.54). CONCLUSION: Our findings are of concern since they demonstrate the high prevalence rate of MDR P. aeruginosa in the majority of Iranian hospitals. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6276320/ /pubmed/30581263 http://dx.doi.org/10.4103/jgid.jgid_113_17 Text en Copyright: © 2018 Journal of Global Infectious Diseases http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Vaez, Hamid
Salehi-Abargouei, Amin
Ghalehnoo, Zahra Rashki
Khademi, Farzad
Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
title Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
title_full Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
title_fullStr Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
title_full_unstemmed Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
title_short Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
title_sort multidrug resistant pseudomonas aeruginosa in iran: a systematic review and metaanalysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276320/
https://www.ncbi.nlm.nih.gov/pubmed/30581263
http://dx.doi.org/10.4103/jgid.jgid_113_17
work_keys_str_mv AT vaezhamid multidrugresistantpseudomonasaeruginosainiranasystematicreviewandmetaanalysis
AT salehiabargoueiamin multidrugresistantpseudomonasaeruginosainiranasystematicreviewandmetaanalysis
AT ghalehnoozahrarashki multidrugresistantpseudomonasaeruginosainiranasystematicreviewandmetaanalysis
AT khademifarzad multidrugresistantpseudomonasaeruginosainiranasystematicreviewandmetaanalysis